Summary. The kinetics of insulin secretion and oxygen uptake in response to D-glucose and tolbutamide were compared in mouse pancreatic islets. In addition~ the role of decreased ATP as a driving force for secretagogue-induced oxygen consumption was examined. D-glucose (10-30 mmol/1) triggered a biphasic insulin release which always coincided with a monophasic increase in islet oxygen uptake. In the presence of Dglucose (5-30mmol/1), tolbutamide (3-500~tmol/1) consistently elicited an initial peak of insulin secretion which was followed by a continued decline. Tolbutamide-induced secretory profiles were accompanied by similar respiratory profiles. Oxygen consumption per ng of insulin released during the test phase was higher after elevation of the glucose concentration than after addition of tolbutamide. In conjunction with 5 or 10 mmol/1 D-glucose, but not with 15 or 30 mmol/1 D-glucose, tolbutamide (30-100timol/1) lowered islet ATP content significantly (p<0.02). Phosphocreatine was not found in isolated islets, although they contained substantial creatine kinase activity. It is concluded that the driving force for tolbutamide-induced oxygen uptake is a decrease in the phosphorylation potential caused by the work load imposed by stimulation of the secretion process. However, a major proportion of the respiratory response to glucose also results from enhancement of biosynthesis.
Glucose metabolism in the pancreatic B cell has been suggested to control both secretion and biosynthesis of insulin [1] . Evidence has emerged that fl-cytotropic fuels and their analogues stimulate insulin release via a primary enhancement of hydrogen (reducing equivalents) supply to the respiratory chain of B cell mitochondria [2] [3] [4] . This implies a putative signal function of the proton motive force across the mitochondrial inner membrane and of the cytosolic phosphorylation potential (free enthalpy for ATP hydrolysis). Recently a K + channel which is blocked by ATP has been found in the B-cell plasma membrane and was proposed to mediate the metabolism-induced depolarization of the B cell [5] [6] [7] . However, glucose concentrations less than half maximally effective on insulin secretion are sufficient to maintain a maximal ATP content of pancreatic islets [8, 9] . Thus, attribution of a major signal function to ATP requires the proof that in B cells the total ATP content is not representative of the ATP concentration in the vicinity of the K + channel.
Sulfonylureas (e.g. tolbutamide) trigger insulin release by acting upon specific receptors in the B-cell plasma membrane [10] , probably by direct inhibition of the same K + channel which is the target for ATP [11] .
These drugs neither stimulate catabolic processes nor cause an increase in the content of reduced pyridine nucleotides [NAD(P)H] in pancreatic islets [12] [13] [14] . Hence, the stimulation of ATP consumption in the B cells due to the work load imposed by the secretory response to sulfonylureas is expected to lower the cytosolic ATP concentration, thereby antagonizing partly the fl-cytotropic effects of nutrient secretagogues. The kinetic of sulfonylurea-induced insulin release which declines after an initial maximum perhaps reflects such an interaction [15, 16] . However, the dependence of this kinetic upon the concentrations of sulfonylureas and nutrients is not established in isolated islets. Furthermore, it is unclear whether the sulfonylurea-induced work load is strong enough to modulate insulin secretion. Firstly, tolbutamide and glibenclamide caused both stimulation and inhibition of islet oxygen (O2) uptake in experiments requiring long incubation periods [17, 18] . Secondly, conflicting results have been published concerning the effects of sulfonylureas on islet content of ATE No change, an increase or a decrease were reported and experimental conditions were used which may produce effects not related to insulin release [8, 12, [18] [19] [20] . Thus, it is not possible to decide whether the re-ported decrease in ATP content of islets reflects the energy requirements of the secretion process [21] .
We have therefore undertaken a detailed comparison of the effects of D-glucose and tolbutamide on insulin secretion and islet energy metabolism in order to elucidate further the role of ATP in the function of the pancreatic B cell.
Materials and methods

Chemicals and media
The following substances were used: 3,5-diaminobenzoic acid hydrochloride from Fluka, Buchs, Switzerland; crystalline rat insulin from Novo, Bagsvaerd, Denmark; 125I-labelled porcine insulin from Behringwerke, Frankfurt, FRG; bovine serum albumin (fracfionV) from Miles, Frankfurt, FRG; imidazole (fluorimetric grade), dithiothreitol, P-creatine, pl, pS_di(adenosine 5') pentaphosphate (Ap5 A, lithium salt), calf thymus DNA (type I), charcoal (hydrochloric acid washed) and glucose-6-phosphate dehydrogenase (EC 1.1.1.49; from Leuconostoc mesenteroides) from Sigma, St. Louis, Mo, USA; collagenase (type IV) from Worthington, Freehold, N J, USA. All other enzymes, the nucleotides, D-luciferin, glutathion, Tris and triethanolamine were purchased from Boehringer, Mannheim, FRG. Tolbutamide was a gift from Hoechst AG, Frankfurt, FRG. D-Glucose and all other reagents were analytical grade from Merck, Darmstadt, FRG.
Basal medium for isolation, incubation and perifusion of pancreatic islets was prepared as previously described [22] except that for measurement of 02 consumption it was equilibrated with O2/N2/CO2 (12: 7 : 1). As indicated in the Results section, in some experiments calcium was omitted from all media and 1 mmol/l ethylene glycol bis(flaminoethyl ether)-N,N,N',N'-tetracetic acid (EGTA; NaOH to give pH 7.4) was added. Stock solutions (20 mmol/l) of tolbutamide were prepared daily by dissolving tolbutamide in NaOH (50 mmol/1) and adjusting the pH to 8.5 with HC1.
Isolation of pancreatic islets
Pancreatic islets were isolated from male albino mice (NMRI, 11-15 weeks old, fed ad libitum) by collagenase digestion [23] in basal medium supplemented with glucose (5 mmol/1).
Measurement of insulin secretion
Batches of 50 islets were perifused at 0.9 ml/min at 37 °C as detailed previously [24] . At zero time (after perifusion for 44 rain with control medium containing 0, 5, 10, 15 or 30 mmol/1 glucose) the distribution valve of the system was switched to control or test medium. No correction for the dead space between valve and islets (about 0.4 ml) was made. Insulin content of 1-4 min fractions was determined by radioimmunosassay with rat insulin as reference [25] .
Measurement of 02 consumption
0 2 consumption by batches of 90-150 islets was recorded at 37 °C as described previously [26] , except that the response time of the measuring system was 15-30 s for 99% change. After incubation for 45 rain with control medium (0, 5, 10, 15 or 30 mmol/1 D-glucose) the same medium with or without test substance (to give the final glucose or tolbutamide concentrations in the incubation chamber) was injected into the chamber (zero time). O2 consumption by the islets was calculated from the decrease in the pO2 during 1-4 min intervals and from the amount of medium in the closed incubation chamber, with corrections for atmospheric pressure, water vapour and drift, and with Bunsen°s solubility coefficient of 0.0227 ml/ml (at 37 °C). The DNA content of the islets was measured as described [26] . In control experiments insulin secretion was measured by removing 10 ~tl aliquots from the medium. In the presence of 10 or 15 mmol/1 D-glucose, tolbutamide (100 lxmol/1) enhanced insulin secretion with an initial overshoot coinciding with the 02 uptake peaks in separate experiments (Fig. 5) .
Measurement of A TP and P-creatine content
Batches of 30islets were preincubated (45rain) and incubated (15 rain) at 37 °C in 100 lxl of medium as described previously [22] . After preincubation, 90 p.1 of medium were removed and replaced by 90 l-tl of control or test medium. Incubations were stopped by removing rapidly 90 lxl of medium, pipetting 90 Ixl of ice-chilled NaOH (0.1 mol/1) supplemented with EDTA (2 retool/l) into the incubation tube, sonicating the stoppered tube in an ice bath by pressing it for 1 min against the 12 nun tip of a sonifier (Branson type B15P, pulsed mode with 40% duty cycle) and heating the tube for 10 rain at 60 °C. After neutralization with 45 ~1 of Hepes (0.4 mol/1) supplemented with EDTA (2 mmol/l) and ApsA (20 ~tmol/1), ATP and P-creatine were measured according to Lust et al. [27] with minor modifications. Fortylxl-aliquots were mixed with 20txl of reaction mixture (50 mmol/1 imidazole/HC1, pH 7.0, 15 mmol/l MgCI2, 0.2 mg/ml albumin, 0.2 mmol/1 ADP, 24 U/ml creafine kinase) or of the same mixture without ADP and creatine kinase. After 30 min at room temperature, 25 lxl-aliquots were mixed with 100 !11 of luciferase reagent (56mmol/1 Tris/acetate, pH 7.7, 1.5 mmol/1 EDTA, 6retool/1 dithiothreitol, 20mmol/1 magnesium acetate, 0.Smg/ml albumin, 70 lxmol/1 luciferin, 0.6 Ixg/ml-firefly luciferase) and the luminescence was monitored with a Biocounter M2010 (Lumac, Meise, Belgium). Blanks, ATP standards and P-creatine standards were prepared with medium and run through the entire procedure together with samples. The DNA content of the islets was measured in 40 ~tl-aliquots of the neutralized samples using DNA standards in adequate volumes of mixtures of the different media with the neutralized quenching solution [26] .
Measurement of creatine kinase
Pancreatic islets, total pancreas or brain from albino mice were homogenized in 10 mmol/1 Tris/HC1, pH 7.0 at 0 °C immediately after isolation. 10 lxl of the homogenate (corresponding to 1-10 ~g of tissue protein) were added to 1 ml of reaction mixture (1.00 mmol/1 triethanolamine/HC1, pH 7.0, 10mmol/l MgCI2, 20mmol/1 D-glucose, 10 mmol/1 glutathion, 1 mmol/l ADP, 10 mmol/1 AMP, 0.5 mmol/1 NAD +, 0.5U/ml glucose 6-phosphate dehydrogenase, 0.5U/ml hexokinase). After 5 min at 37 °C in the photometer, the reaction was started with 1001xl of P-creatine (350mmol/1) and extinction at 340 nm was recorded after the lag phase. Recordings without P-creatine were used as parallel blanks. The protein content of the homogenares was determined as described [281.
Statistical analysis
Results are presented as mean_+ SEM for independent experiments. Significances were calculated by the two-tailed matched-pairs signed rank test of Wilcoxon or by the two-tailed U-test of Wilcoxon and of Mann and Whitney. p < 0.05 was considered significant. Increase in insulin release or 02 uptake was calculated by subtracting the last value before zero time. For calculation of the ratio of the increase in O2 uptake to the increase in insulin release, the increase in 02 uptake of tests was corrected by subtracting the corresponding increase of controls.
Results
In mouse islets perifused for 44min with 5, 10 or 15 mmol/1 D-glucose, elevation of the medium glucose concentration to 10, 15 or 30mmol/1, respectively, In each separate experiment of the series 3 I~mol/1 or 10 to 500 ktmol/1 tolbutamide enhanced insulin secretion from 1.5 min to 6.5 or 58 min, respectively, as compared to the rate at -2rain. For further details see Figure 2 caused an increase in insulin release which was maximal at 1.5-2.5min in each single experiment and reached a new steady state not later than at 24 min (Fig. 1) . Transition from 30 to 40 mmol/1 D-glucose did not change insulin secretion significantly, indicating that 30 mmol/1 was already maximally effective ( Fig. 1) . Control studies demonstrated that during perifusion without change of glucose concentration at zero time, insulin secretion did not increase in the presence of 5, 10 or 15 mmol/1 D-glucose from zero time up to 58 min (results not shown). When islets were perifused with a slightly effective glucose concentration (10 mmol/l), tolbutamide (3, 10, 30, 100 or 500 Ixmol/1) stimulated a steep increase in insulin release (Fig. 2) culminating at 1.5-3.5 rain and falling to less than 60% of the peak rate at 10 rain in each single experiment. Subsequently insulin secretion decreased more slowly, but at all tolbutamide concentrations the secretory rate at 58 min was significantly (p < 0.05) lower than that at 10 min. The half maximally effective concentration of tolbutamide ranged between 10 ~tmol/1 and 30 ~tmol/1 (Fig. 2) . In each single experiment testing the effect of glucose concentration (5, 10, 15 or 30mmol/1) upon insulin release elicited by 100 ~tmol/1 tolbutamide, rate of insulin secretion at 10 min was lower than that at 1.5-2.5 min and higher than that at 58 min (Fig. 3) . In the absence of glucose, By subtracting the 02 uptake rate at -2 min from the mean 02 uptake rate between 1.5 and 58 rnin, the mean respiratory increase was calculated in each separate experiment. The mean respiratory increase of profiles n, • or © was significantly higher (p < 0.05, U-test) than the mean respiratory increase of the corresponding controls •, • or ~¢ in Figure 4 . Further details are the same as described in the legend to Figure 4 100 ~tmol/1 tolbutamide was ineffective and 500 gmol/1 tolbutamide caused merely an initial peak of insulin re~z lease (peak rate amounting to 0.90 _+ 0.12 ng. rain-1 per o "3 50 islets, n = 6, secretory profile not shown). In the absence of extracellular Ca 2+ ions, there was no secretory =-response to 100 ~tmol/l tolbutamide (in the presence of 10 retool/1 D-glucose, n = 6, results not shown). Fig. 4 ). Then the respiratory rate increased gradually and an initial overshoot was never observed. In control experiments the rate of Oz uptake rose slowly up to 58 min (except in profile ,). In each single experiment of the series O, z~, A, [], • and O (Fig.4) , 02 consumption at 10 rain was lower than at 58 rain. From 5 min up to 58 rain the ratio of the increase in O2 uptake to the increase in insulin release ranged above 170, 44 or 20 pmol of O2/ng of insulin after transition from 5 to a0mmol/1, from 10 to 15mmol/1 or from 15 to 30 mmol/1 glucose respectively. The ratios were calcu- Figures 1 and 4 and from a DNA content of 20 ng/islet (average islet DNA content of the experimental series).
In the presence of 5, 10, 15 or 30 mmol/1 D-glucose, a high concentration of tolbutamide (100 p.mol/1) stimulated O2 uptake in islets by 28, 51, 26 or 12%, respectively, within 2 min (in each series, p < 0.05 for comparison with the last value before zero time) and afterwards the increase in respiration fell rapidly at 5 or 10 mmol/1 D-glucose and slowly at 15 or 30mmol/1 D-glucose (Fig.5) . Low (10 ~tmol/1) or intermediate (30 ] xmol/l) concentrations of tolbutamide, too, enhanced 02 uptake with a maximum at 1.5 to 3 min in each single experiment (Fig. 6 ). In the presence of 10 or 15 mmol/1 D-glucose, the tolbutamide-induced increase in 02 uptake was still significant at 58 min (to < 0.05 for comparison of series [3, • or A in Figures 5 and 6 with the corresponding control series • or • in Figure 4) . In each single experiment of series O, [3, •, A or • in Figure 5 and 6 the peak rate was higher than the rate at 10 •in. Taking into account the gradual increase in O2 consumption which was observed in control experiments (series O, •, and • in Figure 4 ) and which may reflect augmentation of synthesizing reactions, the respiratory responses to tolbutamide decreased continuously up to 58 min in each series in Figures 5 and 6 . The correlation between tolbutamide-induced secretory and respiratory responses is also documented by the ratios of the increase in 02 uptake to the increase in insulin release which are calculated from the experiments of Figures 2-6 and from a DNA content of 20 ng/islet. This ratio ranged between 14 and 22 or between 10 and 14 pmol of O2/ng of insulin from 1.5 to 58 min in the presence of tolbutamide (100~tmol/1) and 10 or 15 mmol/1 D-glucose respectively. Except for two values, all other ratios ranged below 34 pmol of O2/ng of insulin. In the absence of glucose, 500 ~tmol/1 tolbutamide enhanced islet Oz uptake for 12 min. The peak rate was higher by 18 + 3% than the last value before zero time (n = 5, respiratory profiles not shown). In contrast to experiments in the presence of extracellular Ca 2+ ions [261, stirring caused some disintegration of the islets in Ca2+-free media. In the absence of CaZ+ions, there was no respiratory response to 100 ~tmol/1 tolbutamide (in the presence of 10 retool/1 D-glucose, n = 3).
Since changes in the redox state of pyridine nucleotides probably were not the driving force for the 02 consumption initiated by tolbutamide [12] [13] [14] and since previous results were equivocal [8, 12, [18] [19] [20] , we examined the effects of tolbutamide on the ATP content of pancreatic islets. In conjunction with 5 or 10 retool/1 D-glucose, tolbutamide (30 or 100 lxmol/1) lowered islet ATP content significantly (Table 1 , p < 0.02). These effects were prevented in Ca z+-free media. At higher glucose concentrations there was only a trend of lower ATP levels in the presence of tolbutamide (Table t) . Pcreatine was not found in islets incubated at 10 mmol/1 D-glucose (n =10; the detection limit was 15 pmol/~tg of DNA). However, substantial creatine kinase activity was measured in mouse islets (0.47 + 0.05 ~tmol-•in -1. mg-i of protein, n = 7) ranging between the activities in total pancreas (0.17_+ 0.03 ~tmol-•in -a. mg -~ of protein, n = 3) and brain (3.46 ___ 0.45 ~tmol • •in -1. mg -1 of protein, n = 5).
Discussion
Our study confirms that an increase in islet 0 2 consumption starts within a few minutes after elevation of the medium glucose concentration [29, 30] . The initial respiratory responses in the present results were stronger than those observed in the experimental set-up of Hutton and Malaisse [30] . However, the equilibration kinetic in their system was rather slow [30] , as indicated by a comparison with another perifusion system of these authors [31] . In the present study glucose-induced initial secretory maxima were never paralleled by 02 uptake peaks. Similar dissociations between insulin release and 02 consumption occurred in mouse islets exposed to endo-2-aminobicyclo [2.2.1]-heptane-2-carboxylic acid (BCH) [2] . These differences between the secretory and respiratory profiles presumably resulted from the additional work load imposed by fuel-induced synthesizing processes. This view is supported by the finding that omission of calcium from the medium had only small effects on 02 uptake in the presence of nutrient secretagogues [30] . In this situation the release but not the biosynthesis of insulin was inhibited [32] . Furthermore, 02 consumption per ng of insulin released from min 5 to min 60 of the test phase was higher after elevation of the glucose concentration than after addition of tolbutamide, which did not stimulate insulin synthesis [10] . For instance, after transitions from 10 mmol/1 D-glucose to 10 mmol/1 D-glucose + tolbutamide (30 ~tmol/1) or to 15 mmol/1 D-glucose, the ratios of the increase in 02 uptake to the increase in insulin release were 20 or 48 pmol of O2/ng of insulin, respectively, at min 30 (Figs. 1, 2, 4 and 6) . This means that a major proportion of the respiratory response to glucose was not caused by stimulation of the secretory process.
The present finding that only a slight increase in islet 02 uptake was initiated by tolbutamide in conjunction with 5 mmol/1 glucose is in accordance with results obtained by the Cartesian diver technique [17] . However, we found increased respiration in response to tolbutamide in the presence of 15 mmol/1 glucose, whereas Stork et al. [17] observed an inhibitory effect of tolbutamide in the presence of 16.7 mmol/1 glucose. This discrepancy may be due to more efficient exchange of gas, ions, glucose and secretory products between medium and islets in the present experiments since smaller islets were used and since the medium was stirred [26, 33] . Moreover, in the Cartesian diver islet respiration was impaired by the absence of medium bicarbonate [30] .
The correlation between tolbntamide-induced secretory and respiratory profiles in islets and the failure of sulfonylureas to enhance insulin synthesis [10] favour the view that tolbutamide evoked 02 uptake by the work load imposed by stimulation of insulin secretion. Respiration is driven by the disequilibrium between the overall reduction potential span across the respiratory chain and the cytosolic phosphorylation potential [34] . Tolbutamide apparently does not enhance the availability of reducing equivalents in the B-cell mitochondria [12] [13] [14] 21] . Hence, a decrease in the cytosolic phosphorylation potential remains as the driving force for tolbntamide-induced 02 consumption. This decrease was probably reflected in the diminished ATP content of islets incubated at 5 or 10 mmol/1 glucose and at the same tolbntamide concentrations which enhanced islet 02 uptake. This interpretation is supported by inhibition of the secretory, respiratory and ATP-lowering effects of tolbutamide in the absence of extracellular Ca 2+ ions. In the presence of high glucose concentrations (15 or 30 mmol/1) the expected tolbutamide-induced decrease in islet content of ATP coinciding with the increase in 02 consumption was not detected. This was not due to buffering by the P-creatine/creatine system, because Pcreatine was not found in the mouse islets we used in the present study. It is therefore suggested that the total ATP content of islets does not reflect the ATP concentration in cytosolic microenvironments in which major changes in ATP utilization of B cells take place. Substantial microheterogeneity in ATP concentration probably occurs in the cytosol of liver cells [35] .
It has been reported previously that sulfonylureas lowered islet content of ATP not only at low (3.3 or 5.6 mmol/1; [12, 19] ) but also at high (16.7 mmol/1; [12] ) glucose concentrations. The latter discrepancy to our findings may result from the high tolbutamide concentrations (0.74 mmol/1) used, which may have caused additional alterations in B-cell energy metabolism not related to insulin secretion. In the present study tolbutamide in conjunction with 10 mmol/1 glucose was half maximally effective on insulin release at a concentration (around 20 ~tmol/1) in the range of therapeutic plasma concentrations of free tolbntamide [36, 37] .
It has been suggested that the typical decline of the insulin secretory rate during stimulation with tolbutamide was due to slow inactivation of voltage-dependent calcium channels caused by depolarization [16] . However, this hypothesis does not explain why glucose-induced depolarization is accompanied by biphasic insulin release. It is therefore conceivable that the typical decline of the secretory response to tolbutamide reflects decrease in the ATP concentration in the vicinity of the ATP-regulated K + channel. Yet, it is premature to attribute the insulin releasing effects of tolbutamide and glucose solely to a blockade of this K + channel. The Pcreatine content of islets in vivo [38] and the creatine kinase activity in islets indicate that islet cells may lose creatine during the isolation procedure and that the Pcreatine/creatine system could buffer the concentration of cytosolic ATP in vivo. Furthermore, a secretory response to tolbutamide was even observed at a maximally effective glucose concentration which is believed to cause permanent depolarization of B cells [39] . This finding means either that not all B cells are permanently depolarized or that decreasing the membrane potential of B cells is not the sole mechanism by which sulfonylureas elicit insulin release.
